]>
IRCT20210628051728N1 IRCT 2021-07-08 Arak University of Medical Sciences The effect of Montelukast on symptoms of children with bladder pain syndrome Evaluation the effect of Montelukast on urinary symptoms in children with bladder pain syndrome 2021-08-02 anticipated 64 Complete https://irct.ir/trial/57171 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: For dividing patients into two groups block randomization method will be used.This method is used for making balance in allocated cases.The epidemiologist will create randomization sequences by using quadruple blocks(Two cases from control group and two cases from case group) that are produced by the assist of sealed envelope online site and will allocate patients to two groups.As soon as a patient enters the project its status will be determined so the concealment process will be guaranteed. 2-3 Bladder pain syndrome. Intervention 1: Intervention group: Montelukast chewable tablet 5mg in 3-15 year children,10mg in older than 15 year children daily for 14days.This tablet is made in Iran,Dr Abidi pharmaceutical company.Classic treatment consists of Oxybutinin 5mg tablets which is prescribed 0.2mg/kg/dose twice a day in children younger than 5 and 5mg twice a day in older than 5 year old children.It is made in Iran,Iran Daru pharmaceutical company. Intervention 2: Control group: Classic treatment consists of Oxybutinin 5mg tablets which is prescribed 0.2mg/kg/dose twice a day in children younger than 5 and 5mg twice a day in older than 5 year old children.It is made in Iran,Iran Daru pharmaceutical company. Yes - There is a plan to make this available What will be shared: All the individual data of participants When: The access period starts immediately after publishing the results To whom: The information will be available for any researcher. Conditions: There is no limitation. Where to obtain: Faezeh Akbarzadeh via faezeakbarzadeh@yahoo.com / Dr.Ali Arjmand via aliarjmand1@yahoo.com /Dr.Fatemeh Dorreh via fatemeh_dorre@yahoo.com/ Dr.Parsa Yousefi via parsayousefichaijan@yahoo.com How to obtain: The applicant must send his request via email while introducing himself and his reason for information access .Then the data will be sent back by email. Comments:
public Faezeh Akbarzadeh
Arak university of medical sciences,Payambare Azam university complex,Basij Square,Sardasht,Arak
Arak Iran (Islamic Republic of) 3848176941 +98 86 3417 6055 faezeakbarzadeh@yahoo.com Arak University of Medical Sciences scientific Faezeh Akbarzadeh
Arak university of medical sciences,Payambare Azam university complex,Basij Square,Sardasht,Arak
Arak Iran (Islamic Republic of) 3848176941 +98 86 3313 6055 faezeakbarzadeh@yahoo.com Arak University of Medical Sciences Iran (Islamic Republic of) All 3-18 year old children with bladder pain syndrome who were referred to Amirkabir hospital pediatric clinic of Arak city All 3-18 year old children with bladder pain syndrome who were admitted to Amirkabir hospital ward of Arak city Allergy history 3 years 18 years Both Allergy history to Montelukast R39.89 Other symptoms and signs involving the genitourinary system Treatment - Drugs Treatment - Drugs Intervention group: Montelukast chewable tablet 5mg in 3-15 year children,10mg in older than 15 year children daily for 14days.This tablet is made in Iran,Dr Abidi pharmaceutical company.Classic treatment consists of Oxybutinin 5mg tablets which is prescribed 0.2mg/kg/dose twice a day in children younger than 5 and 5mg twice a day in older than 5 year old children.It is made in Iran,Iran Daru pharmaceutical company. Control group: Classic treatment consists of Oxybutinin 5mg tablets which is prescribed 0.2mg/kg/dose twice a day in children younger than 5 and 5mg twice a day in older than 5 year old children.It is made in Iran,Iran Daru pharmaceutical company. Decrease nocturia. Timepoint: days0-14. Method of measurement: questionnaire(numbers). Alleviate bladder pain. Timepoint: days0-14. Method of measurement: questionnaire(mild/moderate/severe). Decrease urinary Incontinency. Timepoint: days 0-14. Method of measurement: questionnaire(numbers). Decrease urinary urgency. Timepoint: days 0-14. Method of measurement: questionnaire(numbers). Decrease urinary frequency. Timepoint: days 0-14. Method of measurement: questionnaire(numbers). Arak University of Medical Sciences Approved 2021-06-12 Ethics commitee of Arak University of Medical Sciences Arak university of medical sciences,Payambare Azam university complex,Basij Square,Sardasht,Arak Arak Markazi Iran (Islamic Republic of)